Outlook Therapeutics (OTLK) Free Cash Flow: 2015-2020
Historic Free Cash Flow for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$12.1 million.
- Outlook Therapeutics' Free Cash Flow fell 126.54% to -$12.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$31.8 million, marking a year-over-year increase of 2.86%. This contributed to the annual value of -$68.8 million for FY2024, which is 60.08% down from last year.
- As of Q3 2020, Outlook Therapeutics' Free Cash Flow stood at -$12.1 million, which was down 102.80% from -$6.0 million recorded in Q2 2020.
- Outlook Therapeutics' Free Cash Flow's 5-year high stood at $55,874 during Q3 2017, with a 5-year trough of -$16.5 million in Q2 2016.
- Moreover, its 3-year median value for Free Cash Flow was -$7.7 million (2018), whereas its average is -$8.2 million.
- Per our database at Business Quant, Outlook Therapeutics' Free Cash Flow surged by 100.52% in 2017 and then crashed by 17,383.46% in 2018.
- Outlook Therapeutics' Free Cash Flow (Quarterly) stood at -$6.0 million in 2016, then plummeted by 62.71% to -$9.7 million in 2017, then decreased by 6.78% to -$10.4 million in 2018, then surged by 35.87% to -$6.7 million in 2019, then plummeted by 126.54% to -$12.1 million in 2020.
- Its last three reported values are -$12.1 million in Q3 2020, -$6.0 million for Q2 2020, and -$7.1 million during Q1 2020.